Covering an area of 3000m², the facility houses a fully equipped micropropagation area, five cultivation rooms, post-processing areas, and an integrated GMP area for the manufacture of phytopharmaceutical products.
Our licensed cultivation area spans 2950m², enabling us to initially produce up to 10 tonnes of dry flower annually, with bi-weekly harvests across five cultivation rooms. Post our planned 2025 stage two expansion, production will increase to over 20 tonnes annually.
